The study demonstrated that estrogen-driven suppression of mRNA, BMPR-II, and Smad1 signaling in PASMCs of non-PAH females contributed to a pro-proliferative phenotype in hPASMCs, potentially predisposing women to PAH. This evidence concerns the gene SMAD1 and pulmonary arterial hypertension.